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High heterogeneity of macrophage is associated with its functions in polarization to different functional phenotypes depending
on environmental cues. Macrophages remain in balanced state in healthy subject and thus macrophage polarization may be
crucial in determining the tissue fate. The two distinct populations, classically M1 and alternatively M2 activated, representing
the opposing ends of the full activation spectrum, have been extensively studied for their associations with several disease
progressions. Accumulating evidences have postulated that the redox signalling has implication in macrophage polarization and
the key roles of M1 andM2macrophages in tissue environment have provided the clue for the reasons of ROS abundance in certain
phenotype. M1 macrophages majorly clearing the pathogens and ROS may be crucial for the regulation of M1 phenotype, whereas
M2 macrophages resolve inflammation which favours oxidative metabolism. Therefore how ROS play its role in maintaining
the homeostatic functions of macrophage and in particular macrophage polarization will be reviewed here. We also review
the biology of macrophage polarization and the disturbance of M1/M2 balance in human diseases. The potential therapeutic
opportunities targeting ROS will also be discussed, hoping to provide insights for development of target-specific delivery system
or immunomodulatory antioxidant for the treatment of ROS-related diseases.
1. Introduction
Accumulating studies have implied the physiological role of
reactive oxygen species (ROS) in various biological processes
at distinct levels, for example, gene expression, protein
translation, posttranslationalmodification, and protein inter-
actions. Instead of merely being a harmful byproduct of
metabolism, cell-derived ROS majorly derived from hydro-
gen peroxide (H
2
O
2
), superoxide anions (O
2
−), and hydroxyl
radicals (OH−), is an independent or cooperative regulator
for cellular signalling in response to environmental cues.
For instance, H
2
O
2
, due to its long-lived nature and ability
to easily pass through cellular membrane, is an important
secondarymessenger inmaintaining the cellular homeostasis
under different conditions [1]. It may result in activation or
shutdown of diverse cellular processes such as cell cycling,
chromatin remodeling, DNA repair, cell differentiation, and
self-renewal [2].The balance of intracellular ROS is therefore
extremely important in maintaining normal physiology of
human beings. While mitochondrial respiratory chain is
the major component that cells used to produce intracel-
lular ROS, cells develop a series of antioxidant enzymes
to reduce redundant ROS. These enzymes, including cata-
lase, superoxide dismutase (SOD), glutathione peroxidase
(GPx), and glutathione reductase (GR), can either grossly
or specifically catalyze different types of ROS. The presence
of other endogenous antioxidants such as peroxiredoxins
and thioredoxins ensures critical monitoring of cellular ROS
level and conserves the normal redox homeostasis. In some
pathological conditions, the redox balance is disturbed when
the intracellular redox system is shifted to oxidized state,
which is defined as oxidative stress. During oxidative stress,
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cells produce oxidized lipids, proteins, and damaged DNA
which would consequently lead to cell death and tissue
damage. In this regard, sustained oxidative stress has been
linked with a series of human progressive diseases such as
hepatitis, diabetes, and cancers.
Macrophages are long-lived innate immune cells that
ubiquitously populate in almost all tissues. The general
source of macrophages is bone marrow derived monocytes,
which migrate to various tissues and adhere to become
mature macrophages. However, studies also revealed that
macrophages can be presented bypassing monocytic stages.
Inmany human diseases, macrophages detect tissue injury or
infections and process the damage or remodeling of wounded
tissues [3]. Macrophages also sense the unfavourable condi-
tions within human body including hypoxic and metabolic
stresses where response of host defense and immune regu-
lation are triggered [4, 5]. All these propose macrophages
as an important regulator in multiple biological processes,
including innate and adaptive immunity, angiogenesis, repro-
duction, and even malignancy [6]. The multiple function of
macrophage is facilitated by its high plasticity in response
to environmental- or self-derived stimulating signals [7].
This macrophage heterogeneity is reflected by functional
polarization of differentiated macrophages and the dynamic
switch between phenotypes. Under physiological condition,
the M1/M2 population remains in mixture state while dis-
oriented shift from M1 to M2 or vice versa results in disease
progression.Multiple signalling pathways and several cellular
stimuli, such as cAMP [8], phospholipid [9], and irons [10],
have been found involved in the functional polarization of
macrophages. To our knowledge, there are not many studies
that highlighted the essential role of ROS in regulating
the functional polarization of macrophages. Thus, in this
review, we discussed the involvement of ROS in macrophage
reprogramming. The biology of macrophage polarization,
disturbance of M1/M2 balance in human diseases, and the
role of ROS in macrophage homeostatic functions were
addressed. How ROS drives macrophages polarization and
the potential therapeutic opportunities targeting ROS were
specifically reviewed and discussed.
2. Biology of Macrophage Polarization
One of the important hallmarks of macrophage is its high
heterogeneity, allowing them to be activated to different
functional statuses with particular properties upon exposure
to endogenous and exogenous inducers in the microenvi-
ronment. Mirroring TH1/TH2 programming, macrophage
could be reprogrammed to classically activated (M1) and
alternatively activated (M2) subsets in response to the sur-
rounding stimuli. Classically activated M1 macrophages are
characterized by its high microbicidal function associated
with the ability to secrete high amount of proinflamma-
tory cytokines such as interleukin-1𝛽 (IL-1𝛽), IL-12, tumor
necrosis factor-𝛼 (TNF-𝛼), and superoxide anions. As to
alternatively activatedM2macrophages, their functionality is
distinct from the classical one which produced high levels of
anti-inflammatorymediators IL-10 and tumor growth factor-
𝛽 (TGF-𝛽) and express cell surface markers such as mannose
receptor (MR/CD206) and scavenger receptor (SR/CD163),
which mainly participate in tissue remodeling, parasitic
clearance, and resolution of inflammation. In healthy subject,
macrophage remains in M1/M2 mixture state; therefore
macrophage polarization is important to determine tissue
fate.The switch of macrophages phenotypes towards extreme
state of either M1 or M2 over time may result in several
disease progressions such as obesity, cancer, and rheumatoid
arthritis. Therefore, understanding the functionality of M1
and M2 macrophages and its role in disease progression may
be crucial.
2.1. M1: The Classically Activated Macrophage. The major
homeostatic function of naive macrophages is clearance of
apoptotic debris, produced during the cellular process. In
response to various endogenous danger signals, macrophage
physiology is altered followed by production of proinflam-
matory mediators and modification of surface markers.
Classical M1 macrophages could be activated by either
interferon-𝛾 (IFN𝛾) secreted by NK cells and adaptive T
helper 1 (TH1) cells or pathogen-associated molecular pat-
terns (PAMPs) released by microorganisms through Toll-
like receptor (TLRs) via MyD88 dependent manner [11].
Meanwhile, stimulation of TLR3 and TLR4 may also activate
MyD88 independent pathway that induces IFN𝛽 secretion.
This pathway ismediated byToll/IL-1 receptor (TIR) domain-
containing adaptor and knockdown of TIR led to blockade of
TLR4 mediated inflammation [12].
The activation of classical M1 macrophages induces large
amount of inflammatory genes and chemokines secretion
which facilitates the antigen presentation and recruitment
of TH1 response for subsequent pathogen killing activity.
Recent studies established the metabolic characteristics for
M1 and M2 macrophages, suggesting that the macrophage
metabolism under pathological condition also governs the
functional phenotypic changes of macrophages [13]. Activa-
tion of M1 macrophages is associated with upregulation of
iron storage protein H ferritin and reduction of ferroportin,
leading to iron retention and inflammation [14]. The gly-
colytic flux is favourable in classical M1 macrophages phe-
notype that involves the expression changes of 6-phospho-
2-kinase isoforms from liver-type to more active ubiquitous
isoenzyme, thereby maintaining the level of fructose-2,6-
bisphosphate [15]. Besides, M1macrophage is associated with
higher aerobic glycolysis and extracellular acidification rate
[16]; increase ofHIF-1𝛼 further associates with IL1𝛽 promoter
andmaintains IL1𝛽 production inM1macrophages.Through
regulating glycolytic flux, blockade of carbohydrate kinase-
like protein CARKL triggers M1 polarization [17] while
pyruvate dehydrogenase kinase 1 PDK1 promotes aerobic
glycolysis in M1 macrophages [18]. Apart from glucose
metabolism, activation of M1 macrophages is accompanied
by increase of COX-2 and reduction of COX-1, thromboxane
A synthase 1, arachidonate 5-lipoxygenase, and leukotriene
A4 hydrolase [19].
2.2. M2: The Alternative Activated Macrophage. In contrast
to classical activated macrophages, innate immune cells such
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as basophils and mast cells and other adaptive cells produce
IL-4 and IL-13 priming M2 alternative phenotype. IL-4
induced M2 macrophages expressed high concentration of
IL-10, decoy receptor IL-1R, IL-1R antagonist, chemokines
CCL22 and CCL17, and intracellular enzyme arginase-1.
All of these ensue the recruitment and activation of TH2
immune response and immune-suppressive function of M2
macrophages. In addition to TH2 immune response, IL-4
induced macrophages stimulate arginase activity by con-
verting arginine to polyamines and collagen precursors that
are crucial for tissue modeling and wound healing. M2
macrophages also produce VEGFA, EGF, and IL-8 that
are responsible for angiogenesis and lymphangiogenesis [7].
Apart from IL-4 induced phenotype, different schemes ofM2
macrophages classification have been proposed due to the
overlapping properties of alternative activated macrophages.
The activation of M2 macrophages stimulated by addition
of either IL-4 and IL-13, TGF𝛽, immune complexes, glu-
cocorticoids, or IL-10 may yield distinct activation profiles
[20].
Cellular metabolism especially lipid metabolism also
incurs important role in providing energy fuel for activa-
tion of alternative M2 macrophages. In iron metabolism,
M2 macrophages increased ferroportin expressions, which
further induced iron export [14]. As opposed to M1 classical
activation, M2-regulated gene transcription occurs in con-
dition favouring of mitochondrial metabolism and oxidative
glucose metabolism, in which the M2 phenotype tends to be
switched towards proinflammatory state under low oxygen
condition [16]. In lipid metabolism, M2 macrophage activa-
tion is associatedwith fatty acid oxidation and its uptake.M2-
secreted lysosomal acid lipase as well as its scavenger receptor
CD36 facilitates uptake of triglycerols, LDL, and VLDL for 𝛽-
oxidation and fatty acid generation [21]. Apart from LDL and
VLDL, high density lipoproteins promote anti-inflammatory
function through ATF3 dependent pathway [22]. Study by
Prieur et al. [23] also postulated that short and saturated
fatty acids favour M1 polarization, while longer and unsat-
urated fatty acids induce M2 anti-inflammatory phenotype.
Therefore, M2 activation is accompanied by upregulation of
arachidonic acid [19], omega-3 polyunsaturated fatty acids
[24], sphingosine 1-phosphate [25], eicosapentaenoic acid,
and docosahexaenoic acid [26]. All the correlation of alterna-
tive M2 activation with lipid metabolism also provides clue
for the important role of M2 activation in atherosclerosis,
obesity, and insulin sensitivity (as discussed later).
2.3. Disruption of M1/M2 Balance in Human Diseases. Clas-
sical M1 macrophages elicit major role in inducing inflam-
mation and clearing of pathogens, whereas alternative M2
macrophages resolve inflammation and are crucial for the
functions of tissue modeling and wound healing.They repre-
sent the opposing ends of the activation spectrum, and either
accumulation of M1/M2 signals may lead to deterioration
of the host. Extensive production of IL1, IL6, and IL23 by
M1macrophages incurs activation of TH17 immune response
and leads to autoimmune disorder progression [27]. Earlier
studiesmay postulate thatmacrophages populations promote
disease progression but many recent studies have proposed
that the proportions of different macrophage phenotypes
contribute to disease progression. There is no absolute
answer on which phenotype is “good” or “bad” as the
switch of resident or recruited macrophages towards M2
phenotype may trigger tumor progression while accumu-
lation of M1 macrophages leads to insulin resistance and
atherosclerosis. Therefore, continuous activation of either
states brings harm to the host and the understanding of how
disruption of M1/M2 in regulating diseases may be essen-
tial. The involvement of M1/M2 in obesity, atherosclerosis,
and cancer is briefly discussed below; the comprehensive
reviews on human diseases have been published elsewhere
[28–30].
2.3.1. Obesity and Insulin Resistance. Adipose tissue macro-
phages (ATM) are predominantly alternative M2 phenotype
in lean subjects, and the ATM are reprogrammed to classi-
cally activatedM1 phenotype with proinflammatory function
upon exposure to free saturated fatty acids produced by adi-
pose tissue, resulting in reduced insulin sensitivity in white
adipose tissue. IL-10 secreted byM2macrophages may be the
responsible cytokine that protects adipocytes from obesity
leading insulin resistance [31]. The free fatty acids will also
trigger production of CCL2 by adipocytes and ATM in order
to promote the recruitment of proinflammatory monocytes
to the inflamed tissue [32]. Knockout of CCR2 in murine
model effectively ameliorated the adipocyte inflammation,
macrophage infiltration, and insulin resistance in obese mice
[33].
2.3.2. Atherosclerosis. Atherosclerosis develops with the
accumulation and trapping of low density lipoproteins (LDL)
in the intima of the arteries, and the modified LDL-induced
secretion of adhesion molecules by endothelial cells recruits
monocytes with proinflammatory phenotype to atheroscle-
rotic lesion, which eventually differentiate into lipid-laden
foam cells [34]. Cholesterol crystal, IFN𝛾, LPS, and oxidized
LDL are known to stimulate M1 activation and M1-activated
cytokines further support the monocyte recruitment and
macrophage retention at the plaque area [35]. Due to the
involvement in plaque destabilization, the proatherogenicM1
populations are predominantly accumulated at the plaques
where they are prone to rupture. As forM2macrophages, they
mostly reside at stable-cell enriched plaque and adventitia.
M2 macrophages tend to prevent foam cell formation and
protect against atherosclerosis.
2.3.3. Cancer. Thegrowth and expansion ofmalignant cells is
complex, which involves gene manipulation as well as estab-
lishment of microenvironment that favours tumor progres-
sion. Many recent studies have highlighted the role of tumor-
associated macrophages in promoting cancer growth, angio-
genesis, invasion, migration, and T cell suppression [36].
In most cancers, macrophages residing in tumor microen-
vironment exhibit M2 phenotype with immunosuppressive
property. In contact with tumor cells, M2 macrophages tend
to derive certain substances such as various growth factors,
4 Oxidative Medicine and Cellular Longevity
chemokines, and proteases that maintain tumor growth and
expansion [37]. Apart from mediating tumor growth and
progression, M2 macrophages interact with other immune
cells and suppress innate and adaptive antitumor immune
response. Depending on the tumor environment, phenotype
of tumor-associated macrophages would be reprogrammed
to M1-like phenotype, which is characterized by the antigen
presenting property and tumoricidal function that favours
tumor regression [38]. M1 macrophages activation increases
expressions of mediators that are responsible for antigen
presentation and costimulation; this may further promote
infiltration of neutrophils to the tumor area leading to
neutrophil-targeted tumor regression [39].
3. Reactive Oxygen Species on Homeostasis
Function of Macrophages
3.1. ROS in Regulating Phagocytosis of Macrophages. Numer-
ous studies have unveiled the diverse regulations of ROS
on the phagocytosis function of macrophage. The regulation
may be controversial, but the discrete role of ROS on
macrophages may be impacted by the different sources of
ROS as well as plasticity of macrophage itself, which would
be discussed in detail below. Asmacrophages are endogenous
scavengers for dying cells in various pathological conditions,
interaction between macrophages with compartments deter-
mines the phagocytic function of macrophages. Dying cells
produce high levels of ROS, which are released into extracel-
lular area when cellular membrane is degraded during cell
death. Attachment of dying cells to macrophages requires
intercellular communication in which ROS may play a role.
On the other hand, extracellular and intracellular ROS may
differentially control the phagocytosis process ofmacrophage
by regulating the ability and capacity of macrophages in
the uptake and degradation of dying compartments. In
this regard, ROS plays a critical regulatory role in deter-
mining the initiation and outcome of cellular phagocyto-
sis.
3.1.1. The Role of ROS from Dying Cells during Phagocytosis.
Engulfment of cells undergoing apoptotic programmed cell
death (PCD) by macrophage is initiated by the presentation
of membrane signals to phagocytes that allows recognition
of dying compartments. Inmacrophage-driven phagocytosis,
these molecules include scavenger receptors, for example,
CD36, immunoglobulin super-familymolecules, CD31, com-
plement receptors, such as C91, sugar and phospholipid-
engaging molecules, for example, lectins and PSR, and some
integrins such as 𝛼v𝛽3. The corresponding components on
cellular membrane of apoptotic cells were less identified, but
structures encompass lipid, carbohydrate, and protein which
are exposed as molecules presenting find-me signals towards
extracellular area during cell apoptosis [40]. These lipids and
proteins presented on membranes of apoptotic cells are gen-
erally regarded as substrates of oxidation reaction containing
dying cell-produced ROS. Indeed, experimental evidence
has shown that oxidation of lipids and proteins by ROS
confers recognition and attachment of macrophage towards
apoptotic cells. By using monoclonal antibody that blocks
the epitopes of oxLDL of apoptotic cells, scientists observed
failure of engulfment of dying cells by murine peritoneal
macrophages [41]. It was further observed that surface pre-
sentation of oxidative modified phosphatidylserines (PS) on
apoptotic cells is essential for macrophage engulfment [42].
The phagocytosis was blocked upon presence of lipoprotein-
associated phospholipase A2 (Lp-PLA2), a secreted enzyme
with high specificity towards PS metabolites. Oxidation of
PS is often observed during cell apoptosis [43]. This gives
rise to the mechanism underlying attenuated phagocytosis
of etoposide-treated cells by macrophage as etoposide is
able to suppress oxidation and externalization of PS of the
apoptotic cells [44]. In addition, some phosphatidylcholine
(PC) species, which are oxidized during early- to late-
apoptotic process, present to the surface of apoptotic cells
are recognized by C-reactive proteins, facilitating clearance
of apoptotic cells by macrophage engulfment [41]. Study
revealed that oxidation of PC (oxPC) was majorly processed
by ROS, in virus-infected cells, and scavenge of ROS by NAC
abrogated oxPC production [45]. Although macrophage
receptors correspond to particular type of oxidized lipids and
proteins have not been fully unveiled, all these studies have
paved the importance of ROS-driven oxidation reaction in
dying cells during initiation of phagocytosis.
3.1.2.The Role of Macrophage ROS in Regulating Phagocytosis.
Besides dying cells, macrophage itself also produces intracel-
lular ROS that is involved in the phagocytic process. It is a
notion that ROS in macrophage is essential for uptake and
clearance of apoptotic cells; however, maintaining high level
of ROS may be harmful to macrophage as, in some studies,
inducible ROS is sufficient to cause macrophage apoptosis
[46]. Hypothesis of adaptive mechanism underlying survival
of macrophage in high ROS condition was ever discussed,
which included increase expressions of DNA repair proteins
[47] and endogenous antioxidative enzymes [48] during
monocyte-macrophage differentiation and classical activa-
tion of macrophage. Production of ROS by macrophage
majorly relies onNox2 gene, and study showed that activation
of Nox2 gene in murine macrophage cell line RAW264.7
as well as primary peritoneal macrophages by carotenoid
lutein induced ROS production that was responsible for
the increased phagocytic activity [49]. Additionally, pro-
duction of mitochondrial ROS (mROS) is able to increase
phagocytosis ofmacrophages. InmROS-driven phagocytosis,
intracellular fatty acids are utilized as fuel for oxidative phos-
phorylation by mitochondria-localizing enzyme encoded
by Immunoresponsive gene 1 (IRG1). 𝛽-oxidation of fatty
acids is associated with mROS production and augments
the bactericidal activity of macrophages [50]. These obser-
vations give rise to the critical role of intracellular ROS
in clearance of apoptotic cells by phagocyte. Besides, NO
produced by phagocytosing macrophages is important for
PS externalization of dying cells [51]. And this was further
proved by the notion that phagocytosis entry requires class
I PI3K product phosphatidylinositol 3,4,5-trisphosphate-
induced ROS production in murine macrophages [52]. In
fact, phagocytosis of macrophages requires Nox2-dependent
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production of extracellular ROS [53], and clinical evi-
dence of essential role of ROS was noted in chronic
granulomatous disease patients, who lack Nox2, owning
macrophages that failed to efficiently engulf apoptotic cells
[54].
Additionally, oxidative burst is also required in the clear-
ance of apoptotic cells by alternatively activatedmacrophages
during wound healing process [53]. However, the increase
of ROS in macrophage during early stage of apoptotic cell
clearance is followed by attenuation of oxidative burst by
PPAR𝛾 activation. In PPAR𝛾-mutantmacrophages, ROS level
was restored due to constituting activation of PKC pathway
during apoptotic cell clearance [55]. Further study revealed
that resolvin D1 (RvD1), one of endogenous proresolving
lipid mediators derived from docosahexaenoic acid, is able to
inactivate Nox2 and inhibits production of ROS after engulf-
ment of apoptotic cells by macrophages, which prevents
macrophage from apoptotic cell death [56]. This indicates
that ROS increase in macrophage is transient during phago-
cytic process of apoptotic cells. Indeed, intracellular level of
ROS within macrophages can be triggered by cells undergo-
ing apoptosis or necrosis. This oxidative burst system helps
macrophages to recognize necrotic cells whose clearance
requests an inflammatory reaction. In necrosis-related cell
death, dying cells release high concentration of high-mobility
group box1 (HMGB1), which triggers inflammatory response
in macrophages [57]. Other molecules like calgranulins and
adenosine triphosphate derived from necrotic cells trigger
Nox2 activation in macrophage and produce more ROS [58,
59]. On the contrary, engulfment of apoptotic cells inhibits
persistent ROS production thereby preventing activation of
a secondary inflammation that is harmful to any bystander
cells.This indicates a host response of engulfed compartment
in the extent of oxidative burst. On the other hand, pathogens
are able to developmechanism in responding tomacrophage-
derived ROS, whichwas observed from the induced arginine-
biosynthetic genes in C. albicans [60]. In summary, the
phagocytosis process of macrophage can be regulated by
ROS, which involves responses of host and engulfed cells
towards oxidative burst.
3.2. ROS in the Control of Death of Macrophage. Increase
of ROS during the differentiation and phagocytosis of
macrophagesmay be harmful to the cells. Although increased
levels of DNA repair proteins and ROS reductase in
macrophage make it become highly ROS-resistant in fighting
against overwhelmed intracellular ROS level [47, 48], it is
still not completely prevented from ROS-associated death.
Death of macrophage may not be favourable during diseases
treatment, as dying macrophages may induce secondary
response of necrotic cell death, which includes release of
proinflammatory cytokines and proteolytic factors that fur-
ther activate inflammation [61]. High level of circulating
heme has been demonstrated to induce necrotic cell death of
macrophage, which is associated with increased intracellular
ROS level. And such macrophage death further affects the
intracellular infection control of, for example, malaria and
sepsis [62]. Study has revealed that a tissue damaging agent
methemoglobin has toxicity towards murine macrophages
by increasing the ROS production. In this case, peripheral
presentation of methemoglobin may lead to multiple tissues
damage as well as immunosuppression [63]. These observa-
tions reveal that an overwhelmed ROS level in macrophage
may lead to diseases-associated cell death. In fact, induc-
tion of cell death by ROS can be primarily due to Nox2
activity on phagosomes [64], as well as secondary responses
towards several extracellular and intracellular factors. It was
found that extracellular oxidatively modified high density
lipoprotein induces ROS level in human-derivedmacrophage
lineage cells, which is associated withmacrophage death [65].
This was similarly observed in human-derived macrophages
treated with oxidatively modified low density lipoproteins
(oxLDL) [66], the mechanism of which may involve acti-
vation of Nox by lysophosphatidylcholine, a side product
of LDL oxidation [67]. Interestingly, the cell death-inducing
effect is not observed in either naive HDL or LDL. The
phenomenon is commonly observed in atherogenesis, in
which the persistent macrophage foam cell death and effe-
rocytosis drive the formation of advanced lesions. Other
factors that could result in ROS-associated cell death in
macrophage include cytokines [68] and free cholesterol [69].
Additionally, some studies revealed that ROS-associated ER
stress may lead to macrophage death upon being challenged
by Mycobacterium tuberculosis and Mycobacterium kansasii
[70, 71], whichmay be related to the presence of their heparin-
binding haemagglutinin antigen [72], indicating that the ER
stress may be the downstream event of elevated ROS in
dying macrophage. Increased ER stress subsequently altered
calcium homeostasis and activated Nox-mediated ROS for-
mation, which eventually led to death of macrophages
[61].
3.3. ROS on Monocyte Recruitment. The circulating mono-
cytes, which derive from hematopoietic stem cells in the
bone marrow and migrate to peripheral blood, have the
capacity of differentiating into tissue macrophages. This is
generally considered as themajor population ofmacrophages
involved in pathophysiological development of human dis-
eases. However, tissue macrophages have distinct mecha-
nisms of hematopoiesis, and embryonic macrophages even
bypassed monocytic stages [73]. The diversity in strain of
macrophages was reflected by their name in particular organs
and tissues, for example, Kupffer cells in the liver and
microglia in the brain. It is a notion that, during disease
progression that involves inflammatory response, inflam-
matory monocytes are developed and exhibited migratory
capacity towards primary sites of the diseases. Deficiency
of CX
3
CR
1
in mice suppressed the activation of monocyte-
derived macrophages in periphery and reduced macrophage
infiltration and microglia proliferation, which subsequently
attenuated brain ROS level and neuron apoptosis [74]. This
gives rise to the notion that oxidative stress may have
correlation with monocyte recruitment in human diseases.
Indeed, it was found that H
2
O
2
may serve as chemoat-
tractant to monocytes, as evidenced by the observation in
zebrafish larvae whose wound produced H
2
O
2
to facili-
tate rapid macrophage recruitment [75]. Overexpression of
UCP2, which relieved oxidative stress and intracellular ROS
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level of THP1 human monocytes, further reduced monocyte
migration and adhesion through cellular monolayer [76].
Oxidative burst is therefore regarded as a favouring environ-
ment for monocyte activation. Previous study showed that
ROS triggered CCL2-induced hyperalgesia in rats, which is
attenuated in the presence of SOD confirming the role of
ROS as facilitator in monocyte recruitment [77]. The authors
also found that ROS level is not elicited in response to
CCL2 in monocytes/macrophages with fewer expressions of
CCL2 receptor, which indicated that intracellular ROS level
may have an independent role in triggering recruitment of
monocytes.
Moreover, metabolic stress may trigger expression of
Nox4 in monocytes, increased intracellular H
2
O
2
produc-
tion, and thereby accelerated THP-1 monocyte migration
[78]. The study also further explained why high fat diet-
induced metabolic stress in mice had higher rate in mono-
cyte chemotactic activity. The localization of Nox4 around
focal adhesion and actin cytoskeleton of human-derived
macrophages, together with the association with adhesion
related proteins, supports the role of ROS in mediating
macrophage motility [79]. The study also further postulated
that ER stress stimulated THP-1 monocytes have augmented
adhesion ability, and deletion of Nox4 blocked this activity.
This further claimed that ER stress induced ROS produc-
tion may be an endogenous factor in facilitating monocyte
chemotaxis. Using Nox inhibitor apocynin or antioxidant
catalase, recruitment ofmonocytes into atherosclerotic lesion
was reduced, which suggested the central role of Nox-
derived ROS in monocyte recruitment in atherosclerosis
[80]. Very interestingly, ROS is associated with macrophage
death (as discussed previously) driven by oxLDL and HDL in
atherosclerosis; and also monocyte accumulation in diseased
mice model proposes ROS as an important regulator for
atherosclerosis progression.
Although the reported studies have highlighted ROS as a
critical mediator of monocyte recruitment, the contribution
of ROS as a chemoattractant of monocytes compared to
others, as well as the factors that raise intracellular ROS
in monocytes during pathophysiological process, remains
unanswered. Previous study proposed that ROS-sensitized
monocytes may have higher chemotactic response towards
chemoattractants CCL5, CCL2, and PDGF-𝛽 [78], yet the
study may not directly delineate the role of ROS in monocyte
recruitment. There are few explanations for the difficulties
of this investigation in deriving the cause-effect relationship:
first, the reported models are insufficient to show the correla-
tion of ROS and monocyte recruitment. Blocking ROS may
drive the inhibition of other chemoattractants that further
reduced monocyte motility; second, it is not clear whether
increased monocyte recruitment is the consequences of
enhanced monocyte proliferation and accumulation; thus
the role of ROS in monocyte recruitment, accumulation,
and proliferation needs to be established; third, monocyte
is hypersensitive to ROS. Monocytes undergo extensive cell
death in response to ROS in dose- and time-dependent
manner [47]; proposed high levels of ROS are fatal to mono-
cytes themselves. Therefore, the role of ROS in monocyte
recruitment needs to be further deciphered.
3.4. The Role of ROS on Monocytes-to-Macrophages Differen-
tiation. Studies have revealed that ROS drives monocytes-
to-macrophages differentiation in in vitro culture of var-
ious types of monocytic cells, regardless of mouse or
human origin. It was observed in human promyelocytic
leukemia cell lines that production of ROS was induced
in line with increased expression of macrophage marker
CD14 during 1 alpha, 25-dihydroxyvitamin D (3) (VD3)
induced differentiation. Regulation of monocyte differenti-
ation is mediated through induction of ROS that further
increases 5-lipoxygenase along with p38 MAPK activation
[81]. In human promonocytic cell line U937, production
of ROS was accelerated during macrophage differentiation
induced by phorbol ester (PMA). This event was driven by
NADPH oxidase, and it was observed that the persistent
induction of Cox-2 along with monocyte differentiation
was blocked by Nox inhibitors, suggesting the critical role
of Nox in functional activation of proinflammatory gene
Cox-2 [82]. Generation of ROS which serves as defense
against invading microbes is regarded as the hallmark of
monocyte/macrophage activation, though it is still not clear
if ROS production directly results in macrophage maturation
[47]. It was observed in the latter study that elimination
of ROS by butylated hydroxyanisole (BHA) and other ROS
inhibitors completely blocked monocyte/macrophage differ-
entiation [83]. NADPH oxidase, in particular, is the molecule
that primed to produce more ROS during macrophage
differentiation. It is a typical ROS generator, and its expres-
sion as well as translocation to plasma membrane was
induced by 1,25-dihydroxyvitamin D3 in human myeloid
leukemia PLB-985 cell in line with increased surface markers
CD11b and CD36 during macrophage differentiation [84].
The study also included in vivo intraperitoneal thioglycol-
late injection-induced mouse peritoneal macrophages model
and findings showed that increased macrophage maturation
is associated with enhanced cellular capacity in oxidizing
LDL.
In lipopolysaccharide- (LPS-) induced macrophage dif-
ferentiation model, it was observed that ROS production
is essential in THP-1 differentiated macrophages for acti-
vation of HIF-1𝛼 and acquired adaptive ability in hypoxic
microenvironment of inflammatory site [85]. It is therefore
reasonable that high ROS level is associated with diseased
environment, mainly because ROS facilitates the differen-
tiated macrophages survival under hypoxic condition. A
similar observation is made on 12-O-tetradecanoylphorbol-
13-acetate- (TPA-) induced THP-1 cells in which activa-
tion of NADPH oxidase-derived ROS is associated with
monocytic differentiation [86]. Interestingly, TPA was found
to decrease expression of endogenous antioxidant enzyme
catalase during human U937 macrophage differentiation. By
applying catalase in TPA-treated monocytes, the differenti-
ation process as well as ROS production was blocked [87],
further confirming the role of ROS in mediating macrophage
differentiation. By silencing the important endogenous redox
homeostasis regulator NF-E2-related factor 2 (NRF2) in
PMA-induced U937 cells, the ROS level is maintained
at high level during macrophage differentiation and this
was followed by higher expressions of proinflammatory
Oxidative Medicine and Cellular Longevity 7
cytokines [88]. Additionally, inactivation of oxidative stress-
quenching molecule PPAR𝛾 during saturated fatty acid-
induced macrophage differentiation supports maintenance
of high intracellular ROS level [89], and this process was
found to involve an induced de novo synthesis of endogenous
PPAR𝛾 inhibitor ceramide [90]. Palmitate, the unsaturated
fatty acid intervention, triggered ceramide production in
macrophages and further derived the mitochondrial super-
oxide production that facilitates macrophage differentiation
[91]. Interestingly, it was also reported that, in unprimed
macrophages, differentiation towards alternative activated
phenotype is ROS-dependent but not in classical activation of
macrophages [83]. Consistent with the study, several studies
also suggested that ROS-inducedmaturation of macrophages
is associated with upregulation of proinflammatory gene
expression [82, 88], the hallmark of classically activated
macrophages. Though it is reasonable as macrophage is
mainly present in inflammation site, this further renders the
questions of correlation between ROS, inflammation, and
macrophage maturation. Further discussion would be made
in the latter section. Taken together, all these evidences have
implied a reprogrammed redoxhomeostasis in differentiating
macrophage from monocytes in terms of maintaining ROS
level facilitating cell maturation.
4. Role of ROS in Macrophage Polarization
4.1. ROS Promotes M1. As mentioned above, M1 macro-
phages possess a high bactericidal function and defence
against invading pathogens is the primary function of M1.
To clear the site of injury, M1 macrophages tend to trigger
the bactericidal response which involves the production of
ROS and NO in contact with pathogen. The phagocytic
function of M1 mainly depends on Nox2 gene, as dis-
cussed previously (Section 3.1.2). Production of ROS and
NO by NADPH oxidase and nitric oxide synthase, in which
both enzymes are generated from NADPH through pentose
phosphate pathway [92], and Nox2 negatively regulates the
phagosomal proteolysis [93]. It is also reported that M1
macrophages have reduced rate of acidification and proton-
pumping activity compared to M2, which facilitates M1
macrophages to efficiently eliminate pathogens [94]. The
effective microbicidal function of M1 macrophages requires
continuous production of ROS followed by delayed matura-
tion of phagosomes. In vitro stimulation of M1 macrophages
with lipopolysaccharides (LPS) promotes recognition by
TLRs, the primary LPS receptor, and, occasionally, LPS binds
to phagocytic MAC1 receptor independent of TLRs [95]. The
association of LPS with receptors drives the production of
ROS and genes alterations. LPS-induced ROS generation is
Nox-dependent and it further supports the ROS-induced
TNF𝛼 production, which is evidenced from the reduced
TNF𝛼 in PHOX−/−mice [96]. Although performed in human
embryonic kidney cells HEK293T, previous study also pro-
posed that LPS-induced ROS production is regulated by
the direct association between cytoplasmic tail of TLR4 and
COOH-terminal of Nox4. RNA interference against Nox4 on
TLR4 expressing cells blocked LPS-induced ROS production
[97]. Besides, ROS may serve as secondary messenger in
the LPS-induced signal transduction, facilitating the regu-
lation of downstream pathways such as mitogen-activated
protein kinase (MAPK) and NF-𝜅B [98]. Activation of these
pathways by H
2
O
2
promotes expression of proinflammatory
genes.
Upon being challenged with TLRs ligands, activation of
TLRs binding on macrophages triggers the translocation of
TRAF6 from TLR signalling complex to evolutionarily con-
served signalling intermediate in Toll pathways (ECSIT) on
outer mitochondrial membrane that primes the generation
of mitochondrial ROS and phagocytosis activity [99]. The
stimulation of mitochondrial ROS production via electron
transport chain in the inner mitochondrial membrane facil-
itates macrophage reprogramming towards M1 phenotype.
It is evidenced by the murine model with overexpressing
catalase in mitochondria, which showed increased bacte-
rial loads after infection compared to wild type. Another
study by Infantino et al. also links ROS production to
homeostatic function of mitochondria in macrophages, in
which it suggested that the mitochondrial citrate carrier
that functions in transporting citrate into cytoplasm exerts
important function in mediating ROS generation upon LPS
induction. By either transient deactivation of citrate carrier or
using citrate carrier inhibitor, BTA attenuated the production
of nitric oxide, ROS, and prostaglandin. And the notion
may be contributed by the acetyl-CoA and oxaloacetate,
the cleavage product of citrate required for the production
of ROS [100]. The production of mitochondrial ROS was
also further explained to be mediated by immunoresponsive
gene 1 (IRG1), which improved oxidative phosphorylation
and thereby increased ROS production in phagosomes.
Using zebrafish infection model, the study demonstrated
that depletion of IRG-1 in macrophage lineage cells failed
to employ fatty acid as their fuels and leads to impaired
ROS production and bactericidal activity [50]. Using genetic
deletion of p47PHOX and gp91PHOX, as well as apocynin,
the NADPH inhibitor promoted the phenotypic changes of
microglial towards M2-like phenotype and increased the
M2-like genes response, which further evidenced the role
of NADPH oxidase in maintaining the phenotype of M1
[101].
M1 macrophages activation is always correlated with
upregulation of TNF𝛼 mediated inflammatory response.
Activation of TNF𝛼 is deemed to depend on interaction
of TNF with TNF receptors that triggers the downstream
signalling, mitogen-activated protein kinases (MAPK) and
I𝜅B-kinases (IKK), that activates NF-𝜅B signalling [98]. It is
reported that H
2
O
2
tends to accumulate in NF-𝜅B deficient
cells when exposed to TNF; the H
2
O
2
further oxidized
the catalytic cysteine of MAPK phosphatases and triggered
activation of MAPK cascades including JNK and p38 MAPK
[102]. Excessive H
2
O
2
also promotes I𝜅B-kinase activation
and drives tyrosine phosphorylation of I𝜅B𝛼, leading to
stimulation of NF-𝜅B signalling [103]. Recent studies pos-
tulated that the macrophage reprogramming towards M1
phenotype along with proinflammatory gene expressions by
small molecules is mediated by activation of MAPK and
NF-𝜅B signalling cascades [104, 105], though involvement of
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ROS was not mentioned. Given that ROS is closely related
to the activation of MAPK and NF-𝜅B, ROS may partially
regulate macrophage polarization towards M1. SIRT2, a
NAD-dependent histone deacetylase, was also found to be
involved in LPS-induced ROS generation in macrophages;
deletion of SIRT2 inhibited NF-𝜅B p65 nuclear translo-
cation and M1 related gene expressions [106]. Moreover,
Nox-derived hydrogen peroxide H
2
O
2
was believed to be
the major ROS in response to microglial activation [107],
as evidenced from the observation that catalase blocked
the MAPK and NF-𝜅B mediated LPS-induced proinflam-
matory genes expressions, but not superoxide dismutase
[108].
Rowlands et al. have postulated that TNF𝛼 in circula-
tion increased mitochondrial Ca2+ and thereby triggers the
endocytosis of TNF𝛼 receptor 1 mediated by TNF𝛼 convert-
ing enzyme TACE. The inflammatory response is further
regulated through stimulation of mitochondrial complexes
to generate ROS and binding of unattached TNF𝛼R1 to
soluble TNF𝛼. It is a negative feedback loop in responding
to TNF𝛼 induced inflammation, in which overexpression of
catalase blocked mitochondrial H
2
O
2
dependent TNF𝛼R1
shedding and thus enhanced the inflammatory response
[109]. This study is performed on lung endothelium, while
another recent study also demonstrated the similar regula-
tion on a mucin glycoprotein MUC1 expressed on alveolar
macrophages. MUC1-expressing M1 macrophages activation
increased MUC1 ectodomain shedding in TACE dependent
manner; the upregulation ofMUC1 is associatedwith blunted
ROS production and phagocytic activity in M1 macrophages
[110]. The findings also further revealed that MUC1-deficient
M0 macrophage has augmented ROS and TNF𝛼 secre-
tion, suggesting the tight regulation of ROS homeostasis in
macrophages for maintaining the proper phagocytic activity
and inflammatory response. The uncoupling protein 2 in
inner mitochondrial membrane also interferes with ROS
production; downregulation of UCP2 by LPS inmurine bone
marrow derived macrophages promotes proinflammatory
cytokine secretions [111].
Besides, the activation of inflammasome followed by
ROS production has been implicated in regulating proin-
flammatory cytokines, IL-1𝛽 and IL18 production; it requires
TLR ligands such as LPS for gene synthesis and second
stimulus produced by DAMP for cleavage of caspase-1,
which further stimulates the protein secretions [112]. The
activation by second stimulus such as ATP will trigger
ROS generation, followed by caspase-1 and inflammasome
activation and cytokine production. Early study postulated
that NADPH-derived ROS is responsible for the upstream of
inflammasome activation. It is evidenced from the blockade
of caspase-1 and cytokine secretion after addition of DPI,
flavoprotein inhibitor of NADPH oxidase, which suggests
that the interaction of ROS with inflammasome exerts
important function for proinflammatory cytokines produc-
tion [113]. However, there is contradicting study suggesting
that superoxide dismutase 1, the antioxidant, also regulates
caspase-1 activation [114]. Apart from that, mitochondrial
derived ROS may also activate inflammasomes, in which
the notion is further substantiated by addition of rotenone
and antimycin A; the respiratory chain inhibitors increased
ROS production followed by IL-1𝛽 secretion [115]. Dele-
tion of dynamin-related protein 1 and the mitochondrial
fission protein indirectly influences the localization ofNLRP3
inflammasome, leading to caspase-1 activation and IL-1𝛽 pro-
duction [116].Though ROSmay be crucial for inflammasome
activation and priming, there is also explanation proposing
that redox signalling in macrophage may be derived from
other cell types, and the inflammasome activation depends
on the redox status in particular to cell types upon PAMP
stimulation. In healthy macrophages, the antioxidant system
is stimulated to counteract the high level of ROS and impaired
antioxidant response leads to low inflammasome activation
and IL-1𝛽 production [117]. Nonetheless, redox signalling
in inflammasome activation is far more complicated as
postulated and studies reported on caspase-8-dependent
inflammasome activation and ROS-induced NLRP3 inflam-
masome priming have been further proposed recently [118,
119]. Yet, there is no definite answer on how ROS impacts
inflammasome activation or priming and more studies are
needed to further justify the mechanisms involved. The
mechanisms involved by M1 macrophages are illustrated in
Figure 1.
4.2. ROS Promotes M2. Depending on the content of intra-
cellular glutathione, the M1 and M2 macrophages are char-
acterized as oxidative and reductive macrophages, suggest-
ing the redox regulation in macrophages physiology [120].
In contrast to M1 macrophages, M2 activation stimulates
increased arginase-1 activity and is accompanied by reduced
ROS and NO generation. The functions of tissue remodeling
and wound healing of M2 macrophages are explained to be
attributed by the macrophages effect in expressing increased
cathepsin S and cathepsin L and reduced NAPDH oxidase
(Nox2) activity, which all improved the phagosomal prote-
olytic activity of M2 (IL-4) macrophages. Reduced Nox2 also
improved the wound healing functions of M2 in degrad-
ing disulphide protein [121]. Furthermore, the interaction
between M2 macrophages with apoptotic bodies triggers
instability of NADPHoxidaseNox2mRNAs through binding
blockade of RNA-binding protein SYNCRIP to Nox2 3󸀠-
UTR. And this further defects the ROS production and leads
to M2 macrophage polarization [122]. In type I diabetes
NOD murine model, the deficiency of NADPH oxidase-
derived superoxide has rendered the skewing of islet resident
macrophages towards M2 phenotype followed by down-
regulation of TNF𝛼 and IL1𝛽 in surrounding environment
and further protects 𝛽-cell from destruction [123]. Besides,
the mutation of cytosolic protein of Nox2, p47phox−/−, also
favours the macrophage reprogramming towards M2 pheno-
type together with upregulation of arginase-1, Ym1, and Fizz1
[124].The notion is also further evidenced in diseased state of
microglia, where deletion of p47phox potentiatesmacrophages
towards M2 upon LPS stimulation followed by increase of
M2 markers IL-4R𝛼, Ym1, Fizz1, Mrc1, CD163, and MARCO.
Addition of apocynin, the inhibitor of NADPH oxidase, also
gives similar trend of outcome and the effect is reversed
upon intervention of IL-4 neutralising antibody [101]. All
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Figure 1: Involvement of ROS in regulatingM1 responsible phagocytic activity and inflammatory response. (a)Multiple pathways are involved
in generating NADPH, followed by ROS production by NADPH oxidase. The high ROS level mainly used to mediate the phagocytic activity
ofM1macrophages. (b) ROS serves as secondmessengermediating the inflammatory response ofM1macrophages, primarily throughMAPK
andNF-𝜅B as well as inflammasome activation.Mt, mitochondrial; FA, fatty acid; G6P, glucose-6-phosphate; R5P, ribulose-5-phosphate; PPP,
pentose phosphate pathway; TCA, tricarboxylic acid cycle.
these further propose depletion of Nox2 accompanied by
ROS reduction which is important for reprogramming of M1
to M2 phenotype.
Apart from the suggested role of NADPH oxidase in
regulating M2 macrophages, superoxide dismutase (SOD)
enzyme, which catalyses superoxide dismutation and was
associated with H
2
O
2
production, also contributed to M2
macrophages activation. Study byHe et al. postulated that Cu,
Zn-SOD−/− mice had abundance of alveolar macrophages
in M1 phenotype, while Cu, Zn-SODTG mice predominantly
expressed M2 macrophage markers. The function of Cu,
Zn-SOD in modulating M2 alternative activation is regu-
lated by redox-dependent STAT6 translocation [125]. Indeed,
previous study revealed the absence of IL-4 related genes
expressions in STAT6 deficient mice upon stimulation by IL-
4. Silencing of STAT6 in T lymphocytes showed incapability
to polarize to Th2 phenotype in the presence of IL-13 or IL-
4. This also further postulated that STAT6 is implicated for
M2 macrophage polarization, given that M2 macrophages
have the same differentiation manner as Th2 lymphocytes
[126].Moreover, as opposed toM1macrophages, extracellular
ATP blocks IL-1𝛽 in M2 macrophages. This was claimed
to be mediated by two mechanisms, the direct blockade
of ROS and inflammasome trapping through clustering of
actin filaments, which are both associated with reduced
ATP plasma membrane ion channel, P2X
7
R [127]. Recent
study also postulated the glucose metabolism related protein
carbohydrate kinase-like protein (CARKL) promotes M2
activation. Reduced pentose phosphate pathway (PPP) flux
in M2macrophages is mediated by CARKL that catalyses the
formation of sedoheptulose-7-phosphate, the intermediate
of PPP. The reduced glucose metabolism activated M2 was
evidenced by addition of metformin and rotenone which
blocked (IL-4) M2 genes expressions. The study also further
observed reduction in NAD by not NAD+ levels which
suggested that CARKL may be important in regulating the
redox balance in glucose metabolism [17].
Although impact of redox signalling or ROS production
in M1 macrophages activation seems to interfere with M2
macrophage priming, study by Zhang et al. postulated that
ROS production is also important for M2 macrophage dif-
ferentiation. Intervention of antioxidant butylated hydrox-
yanisole BHA by inhibiting Nox-mediated O2− production
before differentiation by M-CSF treatment blocked mono-
cyte differentiation to M2, which suggests that ROS may
implicate the early stage of M2 macrophage differentiation.
Further intervention of BHA in urethane-induced murine
lung cancer model also attenuated the occurrence of tumor-
associated macrophages and thereby reduced tumor progres-
sion [83]. Also, study revealed that KLF4 triggers MCP-1-
induced protein (MCPIP) to stimulate ROS production in IL-
4-inducedM2macrophages andROS attenuation blocked ER
stress inM2macrophages. Removal of theMCPIP shifted the
macrophage phenotype towards M1 with increasing phago-
cytic function [128]. These studies may render questions
for activation and priming of alternative M2 macrophages,
whether ROS may impact different stages of M2 macrophage
manifestation, which need to be further investigated. The
mechanisms involved by M2 macrophages are illustrated in
Figure 2.
5. Discussion
5.1. ROS-Controlled Macrophage Polarization in Disease Pro-
gression: A Potential Drug Target? More evidences postulated
that macrophage polarization played critical role in initiation
and progression of multiple human diseases, as described
above. In some cases, ROS plays a critical part in triggering
disease-specific skewing of macrophages. This has been
particularly observed in tumorigenesis and atherosclerosis
in which the dysregulation caused by oxidative stress and
inflammation have been extensively studied. However, the
involvement of oxidative stress in diseases progression may
be very broad and results in pathogenesis linking variety
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Figure 2: Involvement of ROS in regulating M2 responsible inflammation resolving and wound healing activities. Multiple pathways
are involved in reducing NADPH and its oxidase followed by reduced ROS generation. The low ROS level was accompanied by
reduced inflammatory mediators; increased M2-regulated genes responsible for inflammation resolution; and increased disulphide protein
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pathway; SYNCRIP, synaptotagmin binding, cytoplasmic RNA interacting protein; SOD, superoxide dismutase.
levels of biological processes; direct cues on ROS-directed
macrophage polarization further dominate diseases pro-
gression which are still lacking. This is also not justified
due to the nature of macrophages as effectors cells, whose
function in part is antigen presenting. In this case, ROS-
drivenmacrophage polarization is thus far difficult to become
putative drug target owing to the lack of specificity. This
shortage is reflected in multiple levels, and pharmaceutical
companies have to develop systems that particularly target
macrophage ROS as well as its polarization.This includes not
only drug target study but also development of drug deliv-
ery system. Interestingly, recent studies have revealed that
liposome specifically delivered molecules to macrophages
[129], which allows molecules to be specifically targeted
on macrophages in the body. And development of high-
resolution transcriptome analysis allows differentiation of
M1 macrophages from M2 phenotype by specific surface
markers [130]. Development of particular antibodies also
allows recognition of individual subtype of macrophages in
human body. Potential molecules targeting ROS signalling
and macrophage reprogramming could be further enriched
in order to discover the target treatment. More experimental
investigations as well as clinical trials shall be conducted to
prove the hypothesis.
5.2. Antioxidative Herbal Supplements RegulatingMacrophage
Polarization: Any Clues for Diseases Treatment? There are
a plenty of herbal supplements available for the indication
of health improvement. Herbal supplements are commonly
employed, by people not only in Asian countries with
tradition of using herbal remedy for diseases treatment, but
also in countries where use of herbal products is under
strict control and closed monitoring, for example, Europe
and US. There are an increasing number of populations who
favour herbal products as dietary supplements due to the
concrete health-improving effect of herbal supplements as
demonstrated from the scientific evidences by both benchtop
and clinical studies. Most of these herbal supplements, such
as Ginkgo biloba, lingzhi mushroom, baicalin, and some
composite herbal formulae, exhibit excellent antioxidative
effect in laboratory studies. Indeed, herbal supplements gen-
erally contain a series of flavone and phenol-like compounds
that work as effective scavengers of ROS and that confer
the health-improving effects. Interestingly, recent evidences
demonstrated that some herbal supplements could regulate
macrophage polarization in preclinical models of human
diseases. Study by Lam et al. proved that PHY906, an
herbal adjuvant derived from ancient Chinese Medicine
formula Huangqin Decoction, has beneficial effect to cancer
treatment. The tumor regression effect of PHY906 may be
associated with its regulation on polarization of macrophage
within tumormicroenvironment. Tumor frommice receiving
PHY906 showed more infiltrated M1 macrophages which
facilitates tumor cells killing activity [131]. Our previous study
on baicalin, which is the major compound in PHY906 and is
used as calming and soothing supplement, could reskew M2
polarized macrophages towards M1 phenotype. This effect
was reflected in tumor microenvironment, with more M1 but
reduced M2 macrophages observed after baicalin treatment.
Removal of macrophages attenuated tumor inhibition by
baicalin [132]. Interestingly, baicalin is generally used to
reduce inflammation. The property of baicalin and baicalin-
containing herbal supplement in activating proinflammatory
phenotype of tumor-associated macrophages may under-
score a variety of mechanisms underlying effect of baicalin
on macrophages. In fact, baicalin has been reported as a
ROS generator as well as scavenger in macrophages [133,
134]. Given the complicated role of ROS as we discussed
above, the dual role of baicalin in ROS homeostasis may be
involved in baicalin-mediated proinflammatory macrophage
skewing. More scientific evidences have to be acquired in
order to prove if ROS involves baicalin-mediatedmacrophage
functions, but this also further raises the consideration on
the scientific scrutiny in consumption of herbal products as
Oxidative Medicine and Cellular Longevity 11
daily dietary supplements, assuming that they may impact
ROS-driven macrophages polarization. Similar cases are
reported in other antioxidative herbal supplements, includ-
ing bitter mushroom [135] and lingzhi mushroom [136],
which facilitates the regulation of macrophage polarization
towards particular phenotype. Nonetheless, the function
of polarized macrophages with particular phenotype varies
across different diseases, and there is no justifiable con-
clusion on the function of each individual phenotype of
macrophages in all diseases. In this case, herbal supplements
consumption without concerning their use in particular
diseases may cause severe consequences, at least in the
context of macrophage polarization. As we still could not
deny the drug-like effect of many herbal supplements, their
proper use shall be further supported by more scientific
evidences.
6. Conclusion
In summary, macrophages are majorly diversified into
two distinct phenotypes. A variety of peripheral and resi-
dence factors may determine the dominant phenotypes of
macrophages within tissues. Although it is not yet concluded
whether this polarization of macrophages is in situ reversible,
it has been shown that the overall shift of macrophage
phenotypes plays a critical role in the progression of various
human diseases. Instead ofmerely being a harmful byproduct
of metabolism, ROS has been shown to get involved in the
functional and phenotypic regulation of macrophages. ROS
is able to control the cell death, proliferation, motility, and
phagocytic ability of macrophages. Intriguingly, it is recently
observed that ROS may play a complicated role in regu-
lating macrophage polarization, which implies the potent
future therapeutic approaches for life-threatening diseases.
Development of target-specific delivery system has been
supportive for drug development, and natural antioxidants
with immunomodulatory function shall be considered. More
scientific evidences as well as clinical trials are imperative and
emerging.
Competing Interests
The authors declare no competing interests.
Authors’ Contributions
Hor-Yue Tan and Ning Wang drafted the paper; Sha Li,
Ming Hong, and Xuanbin Wang revised the paper. Yibin
Feng conceived, designed, revised, and finalized the paper. All
authors discussed and confirmed the final paper.
Acknowledgments
This research was partially supported by the Research
Council of the University of Hong Kong (Project codes:
104002889 and 104003422), Wong’s donation (Project code:
200006276), the donation of Gaia Family Trust, New Zealand
(Project code: 200007008), the donation of Vita Green
Health Products Co., Ltd. (Project code: 200007477), and
the Open Project of Hubei Key Laboratory of Wudang Local
Chinese Medicine Research, Hubei University of Medicine
(WDCM001).
References
[1] K. M. Holmstro¨m and T. Finkel, “Cellular mechanisms and
physiological consequences of redox-dependent signalling,”
Nature ReviewsMolecular Cell Biology, vol. 15, no. 6, pp. 411–421,
2014.
[2] C. L. Bigarella, R. Liang, and S. Ghaffari, “Stem cells and the
impact of ROS signaling,” Development, vol. 141, no. 22, pp.
4206–4218, 2014.
[3] D. Zhou, C. Huang, Z. Lin et al., “Macrophage polarization and
function with emphasis on the evolving roles of coordinated
regulation of cellular signaling pathways,” Cellular Signalling,
vol. 26, no. 2, pp. 192–197, 2014.
[4] D. Lecca, M. L. Trincavelli, P. Gelosa et al., “The recently
identified P2Y-like receptor GPR17 is a sensor of brain damage
and a new target for brain repair,” PLoS ONE, vol. 3, no. 10,
Article ID e3579, 2008.
[5] M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello,
“Obesity in C57BL/6J mice is characterized by adipose tissue
hypoxia and cytotoxic T-cell infiltration,” International Journal
of Obesity, vol. 32, no. 3, pp. 451–463, 2008.
[6] G. Dhabekar, R. Dandekar, and A. Kingaonkar, “Role of
macrophages in malignancy,” Annals of Maxillofacial Surgery,
vol. 1, no. 2, pp. 150–154, 2011.
[7] S. K. Biswas and A. Mantovani, “Macrophage plasticity and
interaction with lymphocyte subsets: cancer as a paradigm,”
Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010.
[8] A. Sica and A.Mantovani, “Macrophage plasticity and polariza-
tion: in vivo veritas,” The Journal of Clinical Investigation, vol.
122, no. 3, pp. 787–795, 2012.
[9] M. J. Rauh, V. Ho, C. Pereira et al., “SHIP represses the
generation of alternatively activated macrophages,” Immunity,
vol. 23, no. 4, pp. 361–374, 2005.
[10] A. Kroner, A. D. Greenhalgh, J. G. Zarruk, R. PassosdosSantos,
M. Gaestel, and S. David, “TNF and increased intracellular iron
alter macrophage polarization to a detrimental M1 phenotype
in the injured spinal cord,” Neuron, vol. 83, no. 5, pp. 1098–1116,
2014.
[11] K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,”Annual
Review of Immunology, vol. 21, pp. 335–376, 2003.
[12] M.Yamamoto, S. Sato,H.Hemmi et al., “Role of adaptorTRIF in
the MyD88-independent toll-like receptor signaling pathway,”
Science, vol. 301, no. 5633, pp. 640–643, 2003.
[13] S. K. Biswas and A. Mantovani, “Orchestration of metabolism
by macrophages,” Cell Metabolism, vol. 15, no. 4, pp. 432–437,
2012.
[14] S. Recalcati, M. Locati, A. Marini et al., “Differential regulation
of iron homeostasis during human macrophage polarized
activation,” European Journal of Immunology, vol. 40, no. 3, pp.
824–835, 2010.
[15] J.-C. Rodr´ıguez-Prados, P. G. Trave´s, J. Cuenca et al., “Substrate
fate in activated macrophages: a comparison between innate,
classic, and alternative activation,” The Journal of Immunology,
vol. 185, no. 1, pp. 605–614, 2010.
[16] E. Izquierdo, V. D. Cuevas, S. Ferna´ndez-Arroyo et al., “Reshap-
ing of human macrophage polarization through modulation of
12 Oxidative Medicine and Cellular Longevity
glucose catabolic pathways,” Journal of Immunology, vol. 195, no.
5, pp. 2442–2451, 2015.
[17] A. Haschemi, P. Kosma, L. Gille et al., “The sedoheptulose
kinase CARKL directs macrophage polarization through con-
trol of glucose metabolism,” Cell Metabolism, vol. 15, no. 6, pp.
813–826, 2012.
[18] Z. Tan, N. Xie, H. Cui et al., “Pyruvate dehydrogenase kinase 1
participates in macrophage polarization via regulating glucose
metabolism,” The Journal of Immunology, vol. 194, no. 12, pp.
6082–6089, 2015.
[19] F. O. Martinez, S. Gordon, M. Locati, and A. Mantovani, “Tran-
scriptional profiling of the human monocyte-to-macrophage
differentiation and polarization: new molecules and patterns of
gene expression,” Journal of Immunology, vol. 177, no. 10, pp.
7303–7311, 2006.
[20] A.Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, andM.
Locati, “The chemokine system in diverse forms of macrophage
activation and polarization,” Trends in Immunology, vol. 25, no.
12, pp. 677–686, 2004.
[21] S. C.-C. Huang, B. Everts, Y. Ivanova et al., “Cell-intrinsic
lysosomal lipolysis is essential for alternative activation of
macrophages,” Nature Immunology, vol. 15, no. 9, pp. 846–855,
2014.
[22] D. De Nardo, L. I. Labzin, H. Kono et al., “High-density
lipoprotein mediates anti-inflammatory reprogramming of
macrophages via the transcriptional regulator ATF3,” Nature
Immunology, vol. 15, no. 2, pp. 152–160, 2014.
[23] X. Prieur, C. Y. L. Mok, V. R. Velagapudi et al., “Differential
lipid partitioning between adipocytes and tissue macrophages
modulates macrophage lipotoxicity and M2/M1 polarization in
obese mice,” Diabetes, vol. 60, no. 3, pp. 797–809, 2011.
[24] D.-S. Im, “Functions of omega-3 fatty acids and FFA4 (GPR120)
in macrophages,” European Journal of Pharmacology, 2015.
[25] S.-J. Park, K.-P. Lee, S. Kang et al., “Sphingosine 1-phosphate
induced anti-atherogenic and atheroprotectiveM2macrophage
polarization through IL-4,”Cellular Signalling, vol. 26, no. 10, pp.
2249–2258, 2014.
[26] M. Masoodi, O. Kuda, M. Rossmeisl, P. Flachs, and J. Kopecky,
“Lipid signaling in adipose tissue: connecting inflammation &
metabolism,” Biochimica et Biophysica Acta (BBA)—Molecular
and Cell Biology of Lipids, vol. 1851, no. 4, pp. 503–518, 2015.
[27] A. Shiomi and T. Usui, “Pivotal roles of GM-CSF in autoimmu-
nity and inflammation,” Mediators of Inflammation, vol. 2015,
Article ID 568543, 13 pages, 2015.
[28] M. J. Kraakman, A. J. Murphy, K. Jandeleit-Dahm, and H.
L. Kammoun, “Macrophage polarization in obesity and type
2 diabetes: weighing down our understanding of macrophage
function?” Frontiers in Immunology, vol. 5, article 470, 2014.
[29] G. Chinetti-Gbaguidi, S. Colin, and B. Staels, “Macrophage
subsets in atherosclerosis,” Nature Reviews Cardiology, vol. 12,
no. 1, pp. 10–17, 2015.
[30] B. Ruffell, N. I. Affara, and L.M. Coussens, “Differential macro-
phage programming in the tumor microenvironment,” Trends
in Immunology, vol. 33, no. 3, pp. 119–126, 2012.
[31] C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a
phenotypic switch in adipose tissue macrophage polarization,”
The Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184,
2007.
[32] A. Chawla, K. D. Nguyen, and Y. P. S. Goh, “Macrophage-
mediated inflammation in metabolic disease,” Nature Reviews
Immunology, vol. 11, no. 11, pp. 738–749, 2011.
[33] S. P. Weisberg, D. Hunter, R. Huber et al., “CCR2 modulates
inflammatory and metabolic effects of high-fat feeding,” The
Journal of Clinical Investigation, vol. 116, no. 1, pp. 115–124, 2006.
[34] S. Colin, G. Chinetti-Gbaguidi, and B. Staels, “Macrophage
phenotypes in atherosclerosis,” Immunological Reviews, vol.
262, no. 1, pp. 153–166, 2014.
[35] K. M. Botham and C. P. D. Wheeler-Jones, “Postprandial
lipoproteins and the molecular regulation of vascular home-
ostasis,” Progress in Lipid Research, vol. 52, no. 4, pp. 446–464,
2013.
[36] B.-Z. Qian and J. W. Pollard, “Macrophage diversity enhances
tumor progression and metastasis,” Cell, vol. 141, no. 1, pp. 39–
51, 2010.
[37] H. Yang, C. Kim, M.-J. Kim et al., “Soluble vascular endothelial
growth factor receptor-3 suppresses lymphangiogenesis and
lymphatic metastasis in bladder cancer,”Molecular Cancer, vol.
10, article 36, 2011.
[38] X. Tang, C. Mo, Y. Wang, D. Wei, and H. Xiao, “Anti-tumour
strategies aiming to target tumour-associated macrophages,”
Immunology, vol. 138, no. 2, pp. 93–104, 2013.
[39] F. Eriksson, P. Tsagozis, K. Lundberg et al., “Tumor-specific
bacteriophages induce tumor destruction through activation
of tumor-associated macrophages,” Journal of Immunology, vol.
182, no. 5, pp. 3105–3111, 2009.
[40] C. D. Gregory and A. Devitt, “The macrophage and the apop-
totic cell: an innate immune interaction viewed simplistically?”
Immunology, vol. 113, no. 1, pp. 1–14, 2004.
[41] M.-K. Chang, C. Bergmark, A. Laurila et al., “Monoclonal
antibodies against oxidized low-density lipoprotein bind to
apoptotic cells and inhibit their phagocytosis by elicited
macrophages: evidence that oxidation-specific epitopesmediate
macrophage recognition,” Proceedings of the National Academy
of Sciences of the United States of America, vol. 96, no. 11, pp.
6353–6358, 1999.
[42] V. A. Tyurin, K. Balasubramanian, D. Winnica et al., “Oxida-
tively modified phosphatidylserines on the surface of apop-
totic cells are essential phagocytic ‘eat-me’ signals: cleavage
and inhibition of phagocytosis by Lp-PLA
2
,” Cell Death and
Differentiation, vol. 21, no. 5, pp. 825–835, 2014.
[43] V. E. Kagan, G. G. Borisenko, B. F. Serinkan et al., “Appe-
tizing rancidity of apoptotic cells for macrophages: oxidation,
externalization, and recognition of phosphatidylserine,” The
American Journal of Physiology—Lung Cellular and Molecular
Physiology, vol. 285, no. 1, pp. L1–L17, 2003.
[44] Y. Y. Tyurina, F. B. Serinkan, V. A. Tyurin et al., “Lipid antioxi-
dant, etoposide, inhibits phosphatidylserine externalization and
macrophage clearance of apoptotic cells by preventing phos-
phatidylserine oxidation,” The Journal of Biological Chemistry,
vol. 279, no. 7, pp. 6056–6064, 2004.
[45] S. Hoshino, M. Konishi, M. Mori et al., “HIV-1 Vpr induces
TLR4/MyD88-mediated IL-6 production and reactivates viral
production from latency,” Journal of Leukocyte Biology, vol. 87,
no. 6, pp. 1133–1143, 2010.
[46] N. Dey, M. Sinha, S. Gupta et al., “Caspase-1/ASC inflam-
masome-mediated activation of IL-1𝛽–ROS–NF-𝜅B pathway
for control of Trypanosoma cruzi replication and survival is
dispensable in NLRP3−/− macrophages,” PLoS ONE, vol. 9, no.
11, Article ID e111539, 2014.
[47] M. Bauer, M. Goldstein, M. Christmann, H. Becker, D. Heyl-
mann, and B. Kaina, “Human monocytes are severely impaired
in base and DNA double-strand break repair that renders
Oxidative Medicine and Cellular Longevity 13
them vulnerable to oxidative stress,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 108, no.
52, pp. 21105–21110, 2011.
[48] S. Essler, N. Dehne, and B. Bru¨ne, “Role of sestrin2 in peroxide
signaling in macrophages,” FEBS Letters, vol. 583, no. 21, pp.
3531–3535, 2009.
[49] H.-M. Lo, C.-L. Chen, C.-M. Yang et al., “The carotenoid
lutein enhances matrix metalloproteinase-9 production and
phagocytosis through intracellular ROSgeneration andERK1/2,
p38 MAPK, and RAR𝛽 activation in murine macrophages,”
Journal of Leukocyte Biology, vol. 93, no. 5, pp. 723–735, 2013.
[50] C. J. Hall, R. H. Boyle, J. W. Astin et al., “Immunoresponsive
gene 1 augments bactericidal activity of macrophage-lineage
cells by regulating 𝛽-oxidation-dependent mitochondrial ros
production,” Cell Metabolism, vol. 18, no. 2, pp. 265–278, 2013.
[51] Y. Y. Tyurina, L. V. Basova, N. V. Konduru et al., “Nitrosative
stress inhibits the aminophospholipid translocase resulting in
phosphatidylserine externalization and macrophage engulf-
ment: implications for the resolution of inflammation,” The
Journal of Biological Chemistry, vol. 282, no. 11, pp. 8498–8509,
2007.
[52] T. Harada, T. Tanikawa, Y. Iwasaki, M. Yamada, Y. Imai,
and M. Miyake, “Phagocytic entry of Legionella pneumophila
into macrophages through phosphatidylinositol 3,4,5-trisphos-
phate-independent pathway,” Biological and Pharmaceutical
Bulletin, vol. 35, no. 9, pp. 1460–1468, 2012.
[53] K. L. Brown, K. Christenson, A. Karlsson, C. Dahlgren, and
J. Bylund, “Divergent effects on phagocytosis by macrophage-
derived oxygen radicals,” Journal of Innate Immunity, vol. 1, no.
6, pp. 592–598, 2009.
[54] D. Sanmun, E. Witasp, S. Jitkaew et al., “Involvement of a
functional NADPH oxidase in neutrophils and macrophages
during programmed cell clearance: Implications for chronic
granulomatous disease,” American Journal of Physiology—Cell
Physiology, vol. 297, no. 3, pp. C621–C631, 2009.
[55] A. M. Johann, A. von Knethen, D. Lindemann, and B. Bru¨ne,
“Recognition of apoptotic cells by macrophages activates the
peroxisome proliferator-activated receptor-𝛾 and attenuates the
oxidative burst,”Cell Death and Differentiation, vol. 13, no. 9, pp.
1533–1540, 2006.
[56] H.-N. Lee and Y.-J. Surh, “Resolvin D1-mediated NOX2 inac-
tivation rescues macrophages undertaking efferocytosis from
oxidative stress-induced apoptosis,” Biochemical Pharmacology,
vol. 86, no. 6, pp. 759–769, 2013.
[57] P. Scaffidi, T. Misteli, and M. E. Bianchi, “Release of chro-
matin protein HMGB1 by necrotic cells triggers inflammation,”
Nature, vol. 418, no. 6894, pp. 191–195, 2002.
[58] S. Y. Lim, M. J. Raftery, J. Goyette, K. Hsu, and C. L. Geczy,
“Oxidativemodifications of S100 proteins: functional regulation
by redox,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 577–
587, 2009.
[59] S. F. Moore and A. B. MacKenzie, “NADPH oxidase NOX2
mediates rapid cellular oxidation following ATP stimulation of
endotoxin-primed macrophages,” Journal of Immunology, vol.
183, no. 5, pp. 3302–3308, 2009.
[60] C. Jime´nez-Lo´pez, J. R. Collette, K. M. Brothers et al., “Candida
albicans induces arginine biosynthetic genes in response to
host-derived reactive oxygen species,” Eukaryotic Cell, vol. 12,
no. 1, pp. 91–100, 2013.
[61] S. Tavakoli and R. Asmis, “Reactive oxygen species and thiol
redox signaling in the macrophage biology of atherosclerosis,”
Antioxidants and Redox Signaling, vol. 17, no. 12, pp. 1785–1795,
2012.
[62] G. B. Fortes, L. S. Alves, R. de Oliveira et al., “Heme induces
programmed necrosis on macrophages through autocrine TNF
and ROS production,” Blood, vol. 119, no. 10, pp. 2368–2375,
2012.
[63] R. Deshmukh and V. Trivedi, “Methemoglobin exposure pro-
duces toxicological effects in macrophages due to multiple ROS
spike induced apoptosis,” Toxicology in Vitro, vol. 27, no. 1, pp.
16–23, 2013.
[64] J. L. Miller, K. Velmurugan, M. J. Cowan, and V. Briken,
“The type I NADH dehydrogenase of Mycobacterium tuber-
culosis counters phagosomal NOX2 activity to inhibit TNF-𝛼-
mediated host cell apoptosis,” PLoS Pathogens, vol. 6, no. 4,
Article ID e1000864, 2010.
[65] V. S. Soumyarani and N. Jayakumari, “Oxidatively modified
high density lipoprotein promotes inflammatory response in
human monocytes-macrophages by enhanced production of
ROS, TNF-𝛼, MMP-9, and MMP-2,” Molecular and Cellular
Biochemistry, vol. 366, no. 1-2, pp. 277–285, 2012.
[66] K. Clare, S. J. Hardwick, K. L. H. Carpenter, N.Weeratunge, and
M. J. Mitchinson, “Toxicity of oxysterols to human monocyte-
macrophages,” Atherosclerosis, vol. 118, no. 1, pp. 67–75, 1995.
[67] U. Rueckschloss, J. Galle, J. Holtz, H.-R. Zerkowski, and H.
Morawietz, “Induction of NAD(P)H oxidase by oxidized low-
density lipoprotein in human endothelial cells: antioxidative
potential of hydroxymethylglutaryl coenzyme A reductase
inhibitor therapy,” Circulation, vol. 104, no. 15, pp. 1767–1772,
2001.
[68] E. Lombardo, A. Alvarez-Barrientos, B. Maroto, L. Bosca´, and
U. G. Knaus, “TLR4-mediated survival of macrophages is
MyD88 dependent and requires TNF-𝛼 autocrine signalling,”
The Journal of Immunology, vol. 178, no. 6, pp. 3731–3739, 2007.
[69] S.-D. Ha, S. Park, C. Y. Han, M. L. Nguyen, and S. O. Kim,
“Cellular adaptation to anthrax lethal toxin-inducedmitochon-
drial cholesterol enrichment, hyperpolarization, and reactive
oxygen species generation through downregulating MLN64 in
macrophages,” Molecular and Cellular Biology, vol. 32, no. 23,
pp. 4846–4860, 2012.
[70] Y.-J. Lim, J.-A. Choi, H.-H. Choi et al., “Endoplasmic reticulum
stress pathway-mediated apoptosis in macrophages contributes
to the survival of Mycobacterium tuberculosis,” PLoS ONE, vol.
6, no. 12, Article ID e28531, 2011.
[71] Y.-J. Lim,H.-H.Choi, J.-A. Choi et al., “Mycobacteriumkansasii-
induced death of murine macrophages involves endoplasmic
reticulum stress responses mediated by reactive oxygen species
generation or calpain activation,” Apoptosis, vol. 18, no. 2, pp.
150–159, 2013.
[72] J.-A. Choi, Y.-J. Lim, S.-N. Cho et al., “Mycobacterial HBHA
induces endoplasmic reticulum stress-mediated apoptosis
through the generation of reactive oxygen species and cytosolic
Ca2+ in murine macrophage RAW 264.7 cells,” Cell Death and
Disease, vol. 4, article e957, 2013.
[73] J. Y. Bertrand, A. Jalil, M. Klaine, S. Jung, A. Cumano, and I.
Godin, “Three pathways to mature macrophages in the early
mouse yolk sac,” Blood, vol. 106, no. 9, pp. 3004–3011, 2005.
[74] Z. Tang, Y. Gan, Q. Liu et al., “CX3CR1 deficiency suppresses
activation and neurotoxicity ofmicroglia/macrophage in exper-
imental ischemic stroke,” Journal of Neuroinflammation, vol. 11,
article 26, 2014.
[75] P. Niethammer, C. Grabher, A. T. Look, and T. J. Mitchison,
“A tissue-scale gradient of hydrogen peroxide mediates rapid
14 Oxidative Medicine and Cellular Longevity
wound detection in zebrafish,” Nature, vol. 459, no. 7249, pp.
996–999, 2009.
[76] J.-W. Ryu, K. H. Hong, J. H. Maeng et al., “Overexpression of
uncoupling protein 2 in THP1 monocytes inhibits 𝛽2 integrin-
mediated firm adhesion and transendothelial migration,” Arte-
riosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 5, pp.
864–870, 2004.
[77] D. Hackel, D. Pflu¨cke, A. Neumann et al., “The connection of
monocytes and reactive oxygen species in pain,” PLoS ONE, vol.
8, no. 5, Article ID e63564, 2013.
[78] S. Ullevig, Q. Zhao, C. F. Lee, H. Seok Kim, D. Zamora, and
R. Asmis, “NADPH oxidase 4 mediates monocyte priming
and accelerated chemotaxis induced by metabolic stress,” Arte-
riosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp.
415–426, 2012.
[79] C. F. Lee, S. Ullevig, H. S. Kim, and R. Asmis, “Regulation of
monocyte adhesion and migration by Nox4,” PLoS ONE, vol. 8,
no. 6, Article ID e66964, 2013.
[80] D. Zhang, X. Jiang, P. Fang et al., “Hyperhomocysteinemia
promotes inflammatory monocyte generation and accelerates
atherosclerosis in transgenic cystathionine 𝛽-synthase- defi-
cient mice,” Circulation, vol. 120, no. 19, pp. 1893–1902, 2009.
[81] L. Stixova´, J. Procha´zkova´, K. Soucˇek, J. Hofmanova´, and
A. Kozubı´k, “5-Lipoxygenase inhibitors potentiate 1𝛼,25-dihy-
droxyvitaminD3-inducedmonocytic differentiation by activat-
ing p38 MAPK pathway,” Molecular and Cellular Biochemistry,
vol. 330, no. 1-2, pp. 229–238, 2009.
[82] S. S. Barbieri, S. Eligini, M. Brambilla, E. Tremoli, and S. Colli,
“Reactive oxygen species mediate cyclooxygenase-2 induction
during monocyte to macrophage differentiation: critical role of
NADPH oxidase,” Cardiovascular Research, vol. 60, no. 1, pp.
187–197, 2003.
[83] Y. Zhang, S. Choksi, K. Chen, Y. Pobezinskaya, I. Linnoila,
and Z.-G. Liu, “ROS play a critical role in the differentiation
of alternatively activated macrophages and the occurrence of
tumor-associatedmacrophages,”Cell Research, vol. 23, no. 7, pp.
898–914, 2013.
[84] B. Fuhrman, M. Shiner, N. Volkova, and M. Aviram, “Cell-
induced copper ion-mediated low density lipoprotein oxidation
increases during in vivo monocyte-to-macrophage differentia-
tion,” Free Radical Biology and Medicine, vol. 37, no. 2, pp. 259–
271, 2004.
[85] K. Nishi, T. Oda, S. Takabuchi et al., “LPS induces hypoxia-
inducible factor 1 activation in macrophage-differentiated cells
in a reactive oxygen species-dependent manner,” Antioxidants
and Redox Signaling, vol. 10, no. 5, pp. 983–995, 2008.
[86] J. Makino, T. Kamiya, H. Hara, and T. Adachi, “TPA induces
the expression of EC-SOD in human monocytic THP-1 cells:
involvement of PKC, MEK/ERK and NOX-derived ROS,” Free
Radical Research, vol. 46, no. 5, pp. 637–644, 2012.
[87] T. Yamamoto, N. Sakaguchi, M. Hachiya, F. Nakayama, M.
Yamakawa, and M. Akashi, “Role of catalase in monocytic
differentiation of U937 cells by TPA: hydrogen peroxide as a
second messenger,” Leukemia, vol. 23, no. 4, pp. 761–769, 2009.
[88] M.-G. Song, I.-G. Ryoo, H.-Y. Choi et al., “NRF2 signaling
negatively regulates phorbol-12-myristate-13-acetate (PMA)-
induced differentiation of human monocytic U937 cells into
pro-inflammatory macrophages,” PLoS ONE, vol. 10, no. 7,
Article ID e0134235, 2015.
[89] C. Pararasa, J. Ikwuobe, S. Shigdar et al., “Age-associated
changes in long-chain fatty acid profile during healthy aging
promote pro-inflammatory monocyte polarization via PPAR𝛾,”
Aging Cell, vol. 15, no. 1, pp. 128–139, 2016.
[90] C. Pararasa, C. Bailey, and H. Griffiths, “Macrophage polari-
sation by fatty acids is PPARgamma-dependent,” Free Radical
Biology and Medicine, vol. 75, supplement 1, pp. S31–S32, 2014.
[91] J. D. Schilling, H. M. Machkovech, L. He et al., “Palmitate and
lipopolysaccharide trigger synergistic ceramide production in
primarymacrophages,” Journal of Biological Chemistry, vol. 288,
no. 5, pp. 2923–2932, 2013.
[92] B. Ghesquie`re, B. W. Wong, A. Kuchnio, and P. Carmeliet,
“Metabolism of stromal and immune cells in health and
disease,” Nature, vol. 511, no. 7508, pp. 167–176, 2014.
[93] J. M. Rybicka, D. R. Balce, M. F. Khan, R. M. Krohn, and
R. M. Yates, “NADPH oxidase activity controls phagosomal
proteolysis in macrophages throughmodulation of the lumenal
redox environment of phagosomes,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 107, no.
23, pp. 10496–10501, 2010.
[94] J. Canton, R. Khezri, M. Glogauer, and S. Grinstein, “Contrast-
ing phagosomepH regulation andmaturation in humanM1 and
M2 macrophages,”Molecular Biology of the Cell, vol. 25, no. 21,
pp. 3330–3341, 2014.
[95] Z. Pei, H. Pang, L. Qian et al., “MAC1 mediates LPS-induced
production of superoxide by microglia: the role of pattern
recognition receptors in dopaminergic neurotoxicity,” Glia, vol.
55, no. 13, pp. 1362–1373, 2007.
[96] L. Qin, Y. Liu, T. Wang et al., “NADPH oxidase mediates
lipopolysaccharide-induced neurotoxicity and proinflamma-
tory gene expression in activated microglia,” Journal of Biologi-
cal Chemistry, vol. 279, no. 2, pp. 1415–1421, 2004.
[97] H. S. Park, H. Y. Jung, E. Y. Park, J. Kim, W. J. Lee, and Y. S.
Bae, “Cutting edge: Direct interaction of TLR4 with NAD(P)H
oxidase 4 isozyme is essential for lipopolysaccharide-induced
production of reactive oxygen species and activation of NF-𝜅B,”
Journal of Immunology, vol. 173, no. 6, pp. 3589–3593, 2004.
[98] C. Kohchi, H. Inagawa, T. Nishizawa, andG.-I. Soma, “ROS and
innate immunity,” Anticancer Research, vol. 29, no. 3, pp. 817–
821, 2009.
[99] A. P. West, I. E. Brodsky, C. Rahner et al., “TLR signalling aug-
ments macrophage bactericidal activity through mitochondrial
ROS,” Nature, vol. 472, no. 7344, pp. 476–480, 2011.
[100] V. Infantino, P. Convertini, L. Cucci et al., “The mitochondrial
citrate carrier: a new player in inflammation,” Biochemical
Journal, vol. 438, no. 3, pp. 433–436, 2011.
[101] S.-H. Choi, S. Aid, H.-W. Kim, S. H. Jackson, and F. Bosetti,
“Inhibition of NADPH oxidase promotes alternative and anti-
inflammatory microglial activation during neuroinflamma-
tion,” Journal of Neurochemistry, vol. 120, no. 2, pp. 292–301,
2012.
[102] H. Kamata, S.-I. Honda, S. Maeda, L. Chang, H. Hirata, and
M. Karin, “Reactive oxygen species promote TNF𝛼-induced
death and sustained JNK activation by inhibiting MAP kinase
phosphatases,” Cell, vol. 120, no. 5, pp. 649–661, 2005.
[103] Y. Takada, A. Mukhopadhyay, G. C. Kundu, G. H. Maha-
beleshwar, S. Singh, and B. B. Aggarwal, “Hydrogen peroxide
activates NF-𝜅B through tyrosine phosphorylation of I𝜅B𝛼 and
serine phosphorylation of p65: evidence for the involvement of
I𝜅B𝛼 kinase and Syk protein-tyrosine kinase,” The Journal of
Biological Chemistry, vol. 278, no. 26, pp. 24233–24241, 2003.
[104] S. Hucke, M. Eschborn, M. Liebmann et al., “Sodium chloride
promotes pro-inflammatory macrophage polarization thereby
Oxidative Medicine and Cellular Longevity 15
aggravating CNS autoimmunity,” Journal of Autoimmunity, vol.
67, pp. 90–101, 2016.
[105] Y. Zhou, T. Zhang, X. Wang et al., “Curcumin modulates
macrophage polarization through the inhibition of the toll-
like receptor 4 expression and its signaling pathways,” Cellular
Physiology and Biochemistry, vol. 36, no. 2, pp. 631–641, 2015.
[106] A. S. Lee, Y. J. Jung, D. Kim et al., “SIRT2 ameliorates lipopol-
ysaccharide-induced inflammation in macrophages,” Biochem-
ical and Biophysical Research Communications, vol. 450, no. 4,
pp. 1363–1369, 2014.
[107] E. A. Bordt and B. M. Polster, “NADPH oxidase- and mito-
chondria-derived reactive oxygen species in proinflammatory
microglial activation: a bipartisan affair?” Free Radical Biology
and Medicine, vol. 76, no. 1, pp. 34–46, 2014.
[108] S. Pawate, Q. Shen, F. Fan, and N. R. Bhat, “Redox regula-
tion of glial inflammatory response to lipopolysaccharide and
interferon𝛾,” Journal of Neuroscience Research, vol. 77, no. 4, pp.
540–551, 2004.
[109] D. J. Rowlands, M. N. Islam, S. R. Das et al., “Activation of
TNFR1 ectodomain shedding by mitochondrial Ca2+ deter-
mines the severity of inflammation inmouse lungmicrovessels,”
The Journal of Clinical Investigation, vol. 121, no. 5, pp. 1986–
1999, 2011.
[110] K. Kato, R. Uchino, E. P. Lillehoj, K. Knox, Y. Lin, and K.
C. Kim, “Membrane-tethered MUC1 mucin counter-regulates
the phagocytic activity of macrophages,” American Journal of
Respiratory Cell and Molecular Biology, vol. 54, no. 4, pp. 515–
523, 2016.
[111] Y. Emre, C. Hurtaud, T. Nu¨bel, F. Criscuolo, D. Ricquier,
and A.-M. Cassard-Doulcier, “Mitochondria contribute to LPS-
induced MAPK activation via uncoupling protein UCP2 in
macrophages,” Biochemical Journal, vol. 402, no. 2, pp. 271–278,
2007.
[112] T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell, “Inflam-
masomes in health and disease,” Nature, vol. 481, no. 7381, pp.
278–286, 2012.
[113] C. M. Cruz, A. Rinna, H. J. Forman, A. L. M. Ventura, P. M.
Persechini, and D. M. Ojcius, “ATP activates a reactive oxygen
species-dependent oxidative stress response and secretion of
proinflammatory cytokines in macrophages,” The Journal of
Biological Chemistry, vol. 282, no. 5, pp. 2871–2879, 2007.
[114] F. Meissner, K. Molawi, and A. Zychlinsky, “Superoxide dis-
mutase 1 regulates caspase-1 and endotoxic shock,” Nature
Immunology, vol. 9, no. 8, pp. 866–872, 2008.
[115] R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, “A role for
mitochondria inNLRP3 inflammasome activation,”Nature, vol.
469, no. 7329, pp. 221–225, 2011.
[116] S. Park, J.-H. Won, I. Hwang, S. Hong, H. K. Lee, and
J.-W. Yu, “Defective mitochondrial fission augments NLRP3
inflammasome activation,” Scientific Reports, vol. 5, Article ID
15489, 2015.
[117] A. Rubartelli, M. Gattorno, M. G. Netea, and C. A. Dinarello,
“Interplay between redox status and inflammasome activation,”
Trends in Immunology, vol. 32, no. 12, pp. 559–566, 2011.
[118] F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Nu´n˜ez, and
V. Hornung, “Cutting edge: reactive oxygen species inhibitors
block priming, but not activation, of the NLRP3 inflamma-
some,” The Journal of Immunology, vol. 187, no. 2, pp. 613–617,
2011.
[119] R. Allam, K. E. Lawlor, E. C.-W. Yu et al., “Mitochondrial
apoptosis is dispensable for NLRP3 inflammasome activation
but non-apoptotic caspase-8 is required for inflammasome
priming,” EMBO Reports, vol. 15, no. 9, pp. 982–990, 2014.
[120] Y. Murata, T. Shimamura, and J. Hamuro, “The polarization
of Th1/Th2 balance is dependent on the intracellular thiol
redox status of macrophages due to the distinctive cytokine
production,” International Immunology, vol. 14, no. 2, pp. 201–
212, 2002.
[121] D. R. Balce, B. Li, E. R. O. Allan, J. M. Rybicka, R. M. Krohn,
and R. M. Yates, “Alternative activation of macrophages by IL-4
enhances the proteolytic capacity of their phagosomes through
synergistic mechanisms,” Blood, vol. 118, no. 15, pp. 4199–4208,
2011.
[122] L. Kuchler, A. K. Giegerich, L. K. Sha et al., “SYNCRIP-
dependent Nox2mRNAdestabilization impairs ROS formation
in M2-polarized macrophages,” Antioxidants and Redox Signal-
ing, vol. 21, no. 18, pp. 2483–2497, 2014.
[123] L. E. Padgett, A. R. Burg,W. Lei, andH.M.Tse, “Loss ofNADPH
oxidase-derived superoxide skews macrophage phenotypes to
delay type 1 diabetes,”Diabetes, vol. 64, no. 3, pp. 937–946, 2015.
[124] L. Yi, Q. Liu, M. S. Orandle et al., “P47(phox) directs murine
macrophage cell fate decisions,” American Journal of Pathology,
vol. 180, no. 3, pp. 1049–1058, 2012.
[125] C. He, A. J. Ryan, S. Murthy, and A. B. Carter, “Acceler-
ated development of pulmonary fibrosis via Cu,Zn-superoxide
dismutase-induced alternative activation of macrophages,”
Journal of Biological Chemistry, vol. 288, no. 28, pp. 20745–
20757, 2013.
[126] M. H. Kaplan, U. Schindler, S. T. Smiley, and M. J. Grusby,
“Stat6 is required for mediating responses to IL-4 and for the
development of Th2 cells,” Immunity, vol. 4, no. 3, pp. 313–319,
1996.
[127] P. Pelegrin and A. Surprenant, “Dynamics of macrophage
polarization reveal new mechanism to inhibit IL-1𝛽 release
through pyrophosphates,”TheEMBO Journal, vol. 28, no. 14, pp.
2114–2127, 2009.
[128] N. Kapoor, J. Niu, Y. Saad et al., “Transcription factors STAT6
and KLF4 implement macrophage polarization via the dual
catalytic powers ofMCPIP,” Journal of Immunology, vol. 194, no.
12, pp. 6011–6023, 2015.
[129] C. Kelly, C. Jefferies, and S. A. Cryan, “Targeted liposomal
drug delivery to monocytes and macrophages,” Journal of Drug
Delivery, vol. 2011, Article ID 727241, 11 pages, 2011.
[130] M. Beyer, M. R. Mallmann, J. Xue et al., “High-resolution
transcriptome of human macrophages,” PLoS ONE, vol. 7, no.
9, Article ID e45466, 2012.
[131] W. Lam, Z. Jiang, F. Guan et al., “PHY906(KD018), an adjuvant
based on a 1800-year-old Chinese medicine, enhanced the anti-
tumor activity of Sorafenib by changing the tumor microenvi-
ronment,” Scientific Reports, vol. 5, article 9384, 2015.
[132] H. Y. Tan, N. Wang, K. Man, S. W. Tsao, C. M. Che, and
Y. Feng, “Autophagy-induced RelB/p52 activation mediates
tumour-associated macrophage repolarisation and suppression
of hepatocellular carcinoma by natural compound baicalin,”
Cell Death and Disease, vol. 6, no. 10, Article ID e1942, 2015.
[133] H.-Y. Lin, S.-C. Shen, C.-W. Lin, L.-Y. Yang, and Y.-C. Chen,
“Baicalein inhibition of hydrogen peroxide-induced apopto-
sis via ROS-dependent heme oxygenase 1 gene expression,”
Biochimica et Biophysica Acta—Molecular Cell Research, vol.
1773, no. 7, pp. 1073–1086, 2007.
[134] L.-L. Liu, L.-K. Gong, H. Wang et al., “Baicalin inhibits
macrophage activation by lipopolysaccharide and protects mice
16 Oxidative Medicine and Cellular Longevity
from endotoxin shock,” Biochemical Pharmacology, vol. 75, no.
4, pp. 914–922, 2008.
[135] F. Sheu, P.-J. Chien, K.-Y. Hsieh et al., “Purification, cloning,
and functional characterization of a novel immunomodulatory
protein from Antrodia camphorata (Bitter Mushroom) that
exhibits TLR2-dependent NF-𝜅B activation and M1 polariza-
tion within murine macrophages,” Journal of Agricultural and
Food Chemistry, vol. 57, no. 10, pp. 4130–4141, 2009.
[136] Y.-K. Zhang, J. Wang, L. Liu, R. C.-C. Chang, K.-F. So, and
G. Ju, “The effect of Lycium barbarum on spinal cord injury,
particularly its relationship with M1 and M2 macrophage in
rats,” BMC Complementary and Alternative Medicine, vol. 13,
article 67, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
